Troy Quander
About Troy Quander
Troy Quander is the Senior Vice President Regulatory & Quality (Chief Regulatory & Quality Officer) at Butterfly Network, Inc., with over 25 years of experience in regulatory affairs, quality, and compliance.
Current Role at Butterfly Network, Inc.
Troy Quander is the Senior Vice President Regulatory & Quality (Chief Regulatory & Quality Officer) at Butterfly Network, Inc. He is based in Massachusetts, United States, and spearheads the organization’s regulatory and quality affairs. His leadership focuses on ensuring compliance with regulatory standards and advancing the company’s innovative medical imaging solutions in global markets.
Previous Experience at Olympus Corporation of the Americas
From 2019 to 2021, Troy Quander served as the Vice President Regulatory Affairs at Olympus Corporation of the Americas. During his tenure, he played a pivotal role in overseeing regulatory strategies and compliance initiatives in Massachusetts, United States. His work contributed significantly to aligning the company's products with health regulations, facilitating smooth market access.
Career at Roche
Troy Quander has an extensive history at Roche, where he served in various leadership roles. From 2016 to 2019, he was the Vice President Quality in the Tucson, Arizona Area. Previously, he was the Vice President Regulatory Affairs from 2012 to 2016, also in Tucson. During his time at Roche, he developed and implemented global regulatory strategies and quality systems, ensuring product compliance and market readiness.
Educational Background
Troy Quander obtained his Bachelor's degree in Biology/Biological Sciences, General from Lincoln University. He studied there from 1984 to 1988, acquiring foundational knowledge that would later support his extensive career in regulatory and quality affairs in the medical and healthcare industry.
Professional Expertise in Regulatory Affairs and Quality
With over 25 years of experience, Troy Quander has significant expertise in Regulatory Affairs, Quality, Regulatory Compliance, and Post Market Quality. He has developed and implemented global regulatory strategies for expedited market access. His experience encompasses the development of INDs/BLAs, IDEs/PMAs, Pre-subs/510ks, Technical Document Files, and International Dossiers. He has also led successful FDA and global health authority inspections and implemented state-of-the-art quality systems and IT tools.